The State Institute for Drug Control (SÚKL) approved the clinical performance study of in vitro diagnostic device Lipidica
At the end of July, a study entitled “Clinical performance of medical device software Lipidica for processing data generated by lipidomic analysis in pancreatic cancer screening” was approved (protocol number: Lipidica_01-2024, version 1.0). The study is registered in the database ClinicalTrials.gov.